Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 61 - 70 of 100+ results
Dr Laura Kenny

Dr Laura Kenny

1.27 miles

Dr Laura Kenny

1.27 miles
Oncology
24 years of experience

Dr Laura Kenny is a Consultant in Medical Oncology and she specialises in breast cancer. She trained in medicine at Queen's University Belfast and after following initial registrar training, she moved to London to study for a PhD in translational molecular imaging in the Cyclotron Building, Imperial College London. Her NHS clinical practice is based at Charing Cross and Hammersmith Hospitals (part of Imperial College  Healthcare NHS Trust) and she also sees patients privately. In addition, Dr Kenny is a Clinical Senior Lecturer at Imperial College.

Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.

She was awarded a prestigious NIHR/MRC clinician scientist fellowship  in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents.  Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.

Dr Kenny was also appointed as Director of  Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK. 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Breast Cancer
Read more
Dr Neel Bhuva

Dr Neel Bhuva

1.27 miles

Dr Neel Bhuva

1.27 miles
Oncology
15 years of experience

Dr Neel Bhuva is a Consultant Clinical Oncologist with an interest in in the specialist non-surgical management of upper and lower gastrointestinal malignancies and general/acute oncology. He is also able to advice on the treatment for cancers of an unknown primary. He has extensive experience delivering radiotherapy, including stereotactic radiotherapy with ‘Cyberknife’, chemotherapy, biological targeted therapy and immunotherapy treatment.

After graduating from Imperial College London, Dr Bhuva undertook his junior medical training at the Hammersmith and Charing Cross Hospitals. Following this, he completed 7 years of specialist training at Mount Vernon, North Middlesex, Imperial College and University College London Hospitals. During this time he completed a Fellowship in radiotherapy at the Royal Marsden Hospital and a postgraduate Master’s degree in Oncology at the Institute of Cancer Research.

Dr Bhuva is a Member of the Royal College of Physicians and a Fellow of the Royal College of Radiologists. He teaches oncology students in London and is an assessor for the Royal College of Radiologists Final Fellowship examination. He is highly active in clinical research and has been published extensively in peer reviewed journals. He is also regularly invited to present his work an both national and international conferences.

He is also a member of the American Society of Clinical Oncology (ASCO) and the European Organisation for Research and Treatment of Cancer (EORTC – Gastrointestinal cancer and Radiation Oncology group).


Diseases, Medical Tests and Treatments
  • Biological Therapy 
  • Chemotherapy 
  • Immunotherapy
  • Radiotherapy 
  • Bowel Cancer 
  • Cancer of Unknown Primary 
  • Gastro-intestinal Cancers 
  • Stomach Cancer 
Read more
Oncology
49 years of experience

Professor Jeffrey Tobias is a Consultant Clinical Oncologist who specialises in Breast cancer and haematological malignancies.


Diseases, Medical Tests and Treatments
  • Breast cancer
  • Myeloma
Read more
Dr Paul Ross

Dr Paul Ross

1.75 miles

Dr Paul Ross

1.75 miles
Oncology
30 years of experience
Medical Oncology

Dr Paul Ross is a leading Consultant Oncologist with HCA Healthcare at London Bridge Hospital, The Lister Hospital and The Harley Street Clinic. He also holds an NHS post at Guy's and St.Thomas' Hospital in South London. His subspeciality includes treating those suffering from cancers of the gastrointestinal tract, liver, gall bladder and pancreas. Additionally, he has vast experience in neuroendocrine tumours. He offers a holistic approach, integrating biological therapies where appropriate. Heis heavily involved in research and is the chief investigator on numerous studies, including locoregional therapy. He is committed to optimising his client's wellbeing and outcomes. 

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Biological Therapy
  • Locoregional Therapy
  • Gastrointestinal Cancer
  • Neuroendocrine Tumours
  • Hepatobiliary Cancer
  • Liver Cancer
  • Upper Gastrointestinal Cancer
  • Lower Gastrointestinal Cancer
  • Pancreatic Cancer
Read more
Dr Mary Lei

Dr Mary Lei

1.75 miles

Dr Mary Lei

1.75 miles
Oncology
20 years of experience
Clinical Oncology

Dr Mary Lei undertook her undergraduate medical training at King's College London School of Medicine and Dentistry and completed specialist training in clinical oncology at Imperial College Healthcare and Guy's and St Thomas' NHS Foundation Trusts.

Dr Lei spent two years as a research fellow in the Royal Surrey County Hospital and the University of Surrey. Her research focused on image-guided intensity-modulated radiotherapy (IMRT) in head and neck cancer and culminated in the award of a Medical Doctorate (MD) postgraduate degree. She was then appointed to a one year charity funded IMRT fellowship in head and neck cancer at Guy's and St Thomas' NHS Foundation Trust.

During her training, Dr Lei was the Chair of the Oncology Trainee Forum, representing the interests of clinical oncology trainees across the UK at the Royal College of Radiologists. She continues to be active in developing clinical oncology training in addition to roles as an educational and clinical supervisor.

Dr Lei has been a consultant clinical oncologist specialising in the treatment of head and neck and thyroid tumours at Guy's and St Thomas' NHS Foundation Trust since 2011. Currently, she is the lead for the clinical oncology radiotherapy research and development (R&D) group and also leads to research and development for the network thyroid cancer team.

Her research interests include novel therapies and predictive biomarkers in head and neck cancer. She is collaborating with colleagues in King's Health Partners on her work in this area.


Diseases, Medical Tests and Treatments


  • Radiotherapy
  • Head
  • Neck
  • Thyroid
  • Neuroendocrine tumours
Read more
Dr Daniel Smith

Dr Daniel Smith

1.75 miles

Dr Daniel Smith

1.75 miles
Oncology
20 years of experience
Clinical Oncology

Dr Daniel Smith is a Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust. He specialises in the treatment of thoracic and breast cancers including: Lung Cancer, Breast Cancer, Mesothelioma, Thymic tumours, Chemotherapy, Radiotherapy. He also delivers immediate post-operative radiotherapy for benign conditions including: Heterotopic Ossification (HO) and Pigmented Villonodular Synovitis (PVNS). He has a particular focus on high precision techniques including 3D and 4D conformal image-guided radiotherapy (IGRT), intensity modulation radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) and stereotactic ablative radiotherapy (SABR).

Dr Smith is the Lead Clinician for Lung Cancer at Guy’s & St Thomas’, one of the largest lung cancer services in the country. He is the Clinical Governance Lead for the Oncology Directorate, has published papers in international journals on IMRT and the incorporation of nuclear medicine into practice, and is an investigator in several active clinical trials. He gained a First Class degree at the University of Cambridge and completed medical training at University College London Medical School. He became a member of the Royal College of Physicians in 2004 and a fellow of the Royal College of Radiologists in 2008 following higher clinical oncology training in North London.


Diseases, Medical Tests and Treatments
  • Immunotherapy
  • Chemotherapy
  • 3D and 4D conformal image-guided radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Volumetric modulated arc therapy (VMAT)
  • Stereotactic Radiotherapy (SABR)
  • Heterotopic Ossification (HO)
  • Pigmented Villonodular Synovitis (PVNS)
  • Lung Cancer
  • Breast cancer
  • Mesothelioma
  • Thymic tumours
Read more
Oncology
16 years of experience
Medical Oncology

Dr Khan is a research-active consultant who trained in medical oncology at the Northern Ireland Cancer Centre and Royal Marsden NHS Foundation Trust London. After working as a Locum Consultant at Royal Marsden for 21 months, he took substantive consultant position in Gastrointestinal Oncology at UCLH. He also attends North Middlesex University Hospital (NMUH), where he is the Clinical Lead of Carcinoma of Unknown Primary (CUP) and Clinical Research in Oncology. Dr Khan was awarded the Robert McAlpine fellowship and studied mechanisms of response and resistance to targeted therapies in advanced colorectal cancer. He gained an MD(Res) degree under the supervision of Professor David Cunningham at the Institute of Cancer Research and the Royal Marsden Hospital. He was involved in setup and conduct of large multi-centre academic and translational studies from the time that he spent in full-time research, which included working as a trial physician for phase II/III studies in early and advanced gastrointestinal cancers.

Dr Khan's main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

He presented and lectured in international conferences and public forums respectively. He published several high impact papers in peer-reviewed journals including Science, Cancer Discovery, Cancer Cell, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Medicine, BMC Cancer, British Medical Journal (BMJ) and British Journal of Cancer. He also served as an expert member of the National Research and Ethics Committee.

Dr Khan also played an active role in improving the educational experience of the junior doctors nationally. He writes questions for MRCP(UK) and Medical Oncology exams and remains part of the national medical oncology recruitment panel. Dr Khan's publications can be accessed via the link below:

https://scholar.google.co.uk/citations?user=yfq8mGcAAAAJ&hl=en&oi=ao

Dr Khan's seceratary Alanna Sarwar can be approached at +44(0)207 317 2659 and she can be emailed directly at asarwar@theloc.com


Diseases, Medical Tests and Treatments
  • Gastrointestinal Cancer Research
  • Colorectal cancers 
  • Colon cancers
  • Rectal cancers
  • Anal cancers 
  • Upper GI Cancers
  • Gastric cancers
  • oesophageal cancers
  • Hepato-biliary malignancies
  • Cholangiocarcinoma
  • Gall bladder cancers
  • Pancreatic cancers
  • Carcinoma of Unknown Primary
  • Gastrointestinal Cancer Research
  • Colorectal cancer
  • Newly diagnosed cancers
  • Molecular Genetics
  • Liquid Biopsies
Read more
Oncology
19 years of experience
Clinical Oncology

Dr Wilson is a Consultant Clinical Oncologist specialising in the treatment of thoracic malignancies (non-small cell lung cancer, small-cell lung cancer, mesothelioma, thymoma). He also offers radiotherapy for skin cancers (basal cell carcinoma, squamous cell carcinoma).

James Wilson completed his DPhil (PhD) at the University of Oxford in 2015, having been awarded a Cancer Research UK/Engineering and Physical Sciences Research Council fellowship. He finished his training at the Royal Marsden Hospital and was awarded a prestigious National Institute for Health Research Clinical Lectureship position at The Institute of Cancer Research in 2016. He is a member of the Royal College of Physicians and fellow of the Royal College of Radiologists.

He is a core member of the oligometastatic multi-disciplinary team (MDT) and offers stereotactic radiotherapy for primary and secondary lung cancers and metastases to the spine, bone and other sites. He represents clinical oncology at the specialist spinal tumour MDT at the National Hospital for Neurology and Neurosurgery.

Dr Wilson has worked in London's leading cancer centres. He is a Consultant Clinical Oncologist at University College London Hospital. As an Associate Professor at UCL he is leading research to improve treatment outcomes for patients. Dr Wilson is a specialist committee member for NICE (National Institute for Health and Care Excellence).

Diseases, Medical Tests and Treatments

Thymoma

Thymic carcinoma

Non-small cell lung cancer

Small cell lung cancer

Read more
Dr Nick Plowman

Dr Nick Plowman

1.25 miles

Dr Nick Plowman

1.25 miles
Oncology
31 years of experience
Clinical Oncology

www.harleystreet-cancer-expert.com

Read more
Oncology
30 years of experience
Medical Oncology

Dr Jeremy Steele trained at St George’s Hospital Medical School, University of London. After a period of training in acute general medical specialities and intensive care medicine, he moved to the Royal Marsden Hospital to train in cancer medicine. There he undertook research into lung cancer, brain tumours and children’s leukaemia. He was awarded the degree of Doctor of Medicine for his thesis on cancer biology. He completed his oncology training at St Bartholomew’s Hospital (Barts) and the Royal London Hospital in London’s East End. In 1999 he was visiting fellow in the thoracic oncology centre of Harvard Medical School, Boston.

East London is the centre of the epidemic of malignant mesothelioma in London, and it was here that he led one of the first effective clinical trials of mesothelioma treatment. In 2002 he was appointed as consultant medical oncologist at Barts with special responsibility for lung cancer and mesothelioma.

Jeremy is well known in the UK as a specialist in lung cancer treatment and is internationally recognised as an expert in malignant mesothelioma diagnosis and treatment. Jeremy is secretary of the International Mesothelioma Group (iMig), based in Chicago, and is chairman of the advisory board of the Mesothelioma UK Charitable Trust. Jeremy has a longstanding commitment to patient advocacy and has successfully lobbied the UK Government on the provision of new cancer treatments.


Diseases, Medical Tests and Treatments
  • Malignant mesothelioma (pleural and peritoneal)
  • Immunotherapy for mesothelioma and lung cancer
  • Maximisation of quality of life
  • Patient-centred cancer care
  • Malignant mesothelioma (pleural and peritoneal)
  • Immunotherapy for mesothelioma and lung cancer
  • Maximisation of quality of life
  • Patient-centred cancer care
Read more